WO2004071386A3 - Compositions comprising microcapsules containing magnetic nanoparticles and biologically active molecules, their preparation and use - Google Patents

Compositions comprising microcapsules containing magnetic nanoparticles and biologically active molecules, their preparation and use

Info

Publication number
WO2004071386A3
WO2004071386A3 PCT/EP2004/001288 EP2004001288W WO2004071386A3 WO 2004071386 A3 WO2004071386 A3 WO 2004071386A3 EP 2004001288 W EP2004001288 W EP 2004001288W WO 2004071386 A3 WO2004071386 A3 WO 2004071386A3
Authority
WO
WIPO (PCT)
Prior art keywords
biologically active
active molecules
compositions
magnetic nanoparticles
preparation
Prior art date
Application number
PCT/EP2004/001288
Other languages
French (fr)
Other versions
WO2004071386A2 (en
Inventor
Giovanni Baldi
Laura Niccolai
Marco Bitossi
Original Assignee
Colorobbia Italiana Spa
Giovanni Baldi
Laura Niccolai
Marco Bitossi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colorobbia Italiana Spa, Giovanni Baldi, Laura Niccolai, Marco Bitossi filed Critical Colorobbia Italiana Spa
Publication of WO2004071386A2 publication Critical patent/WO2004071386A2/en
Publication of WO2004071386A3 publication Critical patent/WO2004071386A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis

Abstract

Compositions containing magnetic nanoparticles and biologically active molecules useful for the intracellular administration of said biologically active molecules are described.
PCT/EP2004/001288 2003-02-13 2004-02-12 Compositions comprising microcapsules containing magnetic nanoparticles and biologically active molecules, their preparation and use WO2004071386A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITFI20030038 ITFI20030038A1 (en) 2003-02-13 2003-02-13 COMPOSITIONS INCLUDING LIPOSOMES CONTAINING NANOPARTICLES
ITFI2003A000038 2003-02-13

Publications (2)

Publication Number Publication Date
WO2004071386A2 WO2004071386A2 (en) 2004-08-26
WO2004071386A3 true WO2004071386A3 (en) 2005-04-21

Family

ID=32866048

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/001288 WO2004071386A2 (en) 2003-02-13 2004-02-12 Compositions comprising microcapsules containing magnetic nanoparticles and biologically active molecules, their preparation and use

Country Status (2)

Country Link
IT (1) ITFI20030038A1 (en)
WO (1) WO2004071386A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8501159B2 (en) 2006-12-18 2013-08-06 Colorobbia Italia S.P.A. Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application
WO2011095661A1 (en) * 2010-02-02 2011-08-11 Consejo Superior De Investigaciones Científicas (Csic) Magnetic nanoparticles for use in a pharmaceutical composition
WO2013019137A1 (en) * 2011-08-04 2013-02-07 Institution Of The Russian Academy Of Sciences Tomsk Scientific Center, Siberian Branch, Russian Academy Of Sciences Oxide ferrimagnetics with spinel structure nanoparticles and iron oxide nanoparticles, biocompatible aqueous colloidal systems comprising nanoparticles, ferriliposomes, and uses thereof
EA029170B1 (en) * 2011-08-04 2018-02-28 Федеральное государственное бюджетное учреждение науки Институт физики прочности и материаловедения Сибирского отделения Российской академии наук (ИФПМ СО РАН) Oxide ferrimagnetics with spinel structure nanoparticles and iron oxide nanoparticles, biocompatible aqueous colloidal systems comprising nanoparticles, ferriliposomes, and uses thereof
US10738174B2 (en) * 2012-04-23 2020-08-11 International Business Machines Corporation Aqueous soluble ferrimagnets stabilized by block copolymers
US10842816B2 (en) * 2017-08-15 2020-11-24 Trustees Of Boston University Compositions and methods for isolating and enriching IgM-producing cells and uses thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4247406A (en) * 1979-04-23 1981-01-27 Widder Kenneth J Intravascularly-administrable, magnetically-localizable biodegradable carrier
DE4201461A1 (en) * 1992-01-21 1993-07-22 Mueller Schulte Detlef Dr Agent for selective hyperthermia and chemotherapy of tumours - consists of ferromagnetic particles encapsulated in matrix which is not phagocyted and is able to couple with antitumour agent
WO1993026019A1 (en) * 1992-06-08 1993-12-23 Molecular Bioquest, Inc. Preparation of controlled size inorganic particles for use in separations, as magnetic molecular switches, and as inorganic liposomes for medical applications
WO1998008094A1 (en) * 1996-08-23 1998-02-26 Amcell Corporation Sensitive detection of cell surface markers on viable cells
WO2001056546A2 (en) * 2000-02-05 2001-08-09 Florida State University Research Foundation Magnetoliposome composition for targeted treatment of biological tissue
WO2001074337A1 (en) * 2000-04-03 2001-10-11 Eucro European Contract Research Gmbh & Co. Kg System for transporting active substances in a biological system

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4247406A (en) * 1979-04-23 1981-01-27 Widder Kenneth J Intravascularly-administrable, magnetically-localizable biodegradable carrier
DE4201461A1 (en) * 1992-01-21 1993-07-22 Mueller Schulte Detlef Dr Agent for selective hyperthermia and chemotherapy of tumours - consists of ferromagnetic particles encapsulated in matrix which is not phagocyted and is able to couple with antitumour agent
WO1993026019A1 (en) * 1992-06-08 1993-12-23 Molecular Bioquest, Inc. Preparation of controlled size inorganic particles for use in separations, as magnetic molecular switches, and as inorganic liposomes for medical applications
WO1998008094A1 (en) * 1996-08-23 1998-02-26 Amcell Corporation Sensitive detection of cell surface markers on viable cells
WO2001056546A2 (en) * 2000-02-05 2001-08-09 Florida State University Research Foundation Magnetoliposome composition for targeted treatment of biological tissue
WO2001074337A1 (en) * 2000-04-03 2001-10-11 Eucro European Contract Research Gmbh & Co. Kg System for transporting active substances in a biological system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WITTENDORP-RECHENMANN, ELISABETH; ET AL.: "Superparamagnetic nanoparticles containing liposomes as potential specific contrast agent for brain MR imaging: initial feasability study by a combined approach with 59Fe-activated track-autoradiography", JOURNAL OF TRACE AND MICROPROBE TECHNIQUES, vol. 16, no. 4, 1998, pages 523 - 534, XP008021042 *

Also Published As

Publication number Publication date
ITFI20030038A1 (en) 2004-08-14
WO2004071386A2 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
PL1792927T3 (en) Novel block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient
WO2000040203A3 (en) Polymeric delivery agents and delivery agent compounds
IL163552A (en) Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same
CA2481848A1 (en) Active ingredient particles carrying clopidogrel or a salt thereof, their use and method of preparation
AU2003215245A1 (en) Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
WO2004064769A3 (en) Methods for making and using topical delivery agents
WO2008009379A3 (en) Active ingredient combinations having insecticide and acaricide properties
WO2005009381A3 (en) Immediate-release formulation of acid-labile pharmaceutical compositions
EP2279732A3 (en) Compounds and compositions for delivering active agents
WO2005027822A3 (en) Stabilized formulations of phosphatidylserine
EP2308479A3 (en) Compounds and compositions for delivering active agents
IS8430A (en) Medicines containing (2R) -2-propyl octanoic acid as the active ingredient
WO2006021001A3 (en) Amphiphilic polynorbornene derivatives and methods of using the same
AU2002238855A1 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
WO2005021706A3 (en) Delivery of compounds with rehydrated blood cells
WO2005065456A3 (en) Active substance combinations having insecticidal properties
HUP0400155A3 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
EP1602362A4 (en) Drug composition having active ingredient adhered at high concentration to spherical core
WO2003018059A3 (en) Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
EP1608395A4 (en) Anticancer agent comprising lk8 protein as an active ingredient
WO2004017943A3 (en) Non-vesicular cationic lipid formulations
ITMI20031396A1 (en) COMPOSITION FOR PHARMACEUTICAL OR DIETETIC OR COSMETIC USE WITH ANTIOXIDANT ACTIVITY.
ITRM20030363A1 (en) COMPOSITIONS INCLUDING 3THIODOTYRONIN AND PHARMACEUTICAL USE OF THEM.
WO2003015780A3 (en) Isoxazolopyridinones and use thereof in the treatment of parkinson's disease
WO2004071386A3 (en) Compositions comprising microcapsules containing magnetic nanoparticles and biologically active molecules, their preparation and use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase